ASP Isotopes Inc. Common Stock
ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for … Read more
ASP Isotopes Inc. Common Stock (ASPI) - Net Assets
Latest net assets as of September 2025: $96.60 Million USD
Based on the latest financial reports, ASP Isotopes Inc. Common Stock (ASPI) has net assets worth $96.60 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($225.89 Million) and total liabilities ($129.29 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $96.60 Million |
| % of Total Assets | 42.77% |
| Annual Growth Rate | 104.3% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 45.76 |
ASP Isotopes Inc. Common Stock - Net Assets Trend (2021–2024)
This chart illustrates how ASP Isotopes Inc. Common Stock's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ASP Isotopes Inc. Common Stock (2021–2024)
The table below shows the annual net assets of ASP Isotopes Inc. Common Stock from 2021 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $51.17 Million | +171.72% |
| 2023-12-31 | $18.83 Million | +91.81% |
| 2022-12-31 | $9.82 Million | +63.69% |
| 2021-12-31 | $6.00 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to ASP Isotopes Inc. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 5356495400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $720.68K | 1.50% |
| Other Comprehensive Income | $-2.16 Million | -4.52% |
| Other Components | $105.52 Million | 220.29% |
| Total Equity | $47.90 Million | 100.00% |
ASP Isotopes Inc. Common Stock Competitors by Market Cap
The table below lists competitors of ASP Isotopes Inc. Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Surgical Science Sweden AB (publ)
PINK:SUSRF
|
$437.81 Million |
|
HALOSOURCE REG S
F:48H
|
$437.97 Million |
|
China Zhonghua Geotechnical Engineering Co Ltd
SHE:002542
|
$438.00 Million |
|
Pharmicell
KO:005690
|
$438.14 Million |
|
Huayi Compressor Co Ltd
SHE:000404
|
$437.73 Million |
|
Beijing Bewinner Communications Co Ltd
SHE:002148
|
$437.69 Million |
|
Cachet Pharmaceutical Co Ltd
SHE:002462
|
$437.62 Million |
|
GRNVLT EN.REN.
F:000
|
$437.62 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ASP Isotopes Inc. Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 16,295,953 to 47,898,492, a change of 31,602,539 (193.9%).
- Net loss of 32,333,581 reduced equity.
- Dividend payments of 2,779,659 reduced retained earnings.
- New share issuances of 53,091,187 increased equity.
- Other comprehensive income decreased equity by 1,243,331.
- Other factors increased equity by 14,867,923.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-32.33 Million | -67.5% |
| Dividends Paid | $2.78 Million | -5.8% |
| Share Issuances | $53.09 Million | +110.84% |
| Other Comprehensive Income | $-1.24 Million | -2.6% |
| Other Changes | $14.87 Million | +31.04% |
| Total Change | $- | 193.93% |
Book Value vs Market Value Analysis
This analysis compares ASP Isotopes Inc. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.78x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 28.47x to 5.78x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | $0.17 | $4.97 | x |
| 2022-12-31 | $0.27 | $4.97 | x |
| 2023-12-31 | $0.49 | $4.97 | x |
| 2024-12-31 | $0.86 | $4.97 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ASP Isotopes Inc. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -67.50%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -780.21%
- • Asset Turnover: 0.04x
- • Equity Multiplier: 1.97x
- Recent ROE (-67.50%) is below the historical average (-64.93%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -43.48% | 0.00% | 0.00x | 1.19x | $-3.21 Million |
| 2022 | -48.80% | 0.00% | 0.00x | 1.27x | $-5.77 Million |
| 2023 | -99.94% | -3761.03% | 0.01x | 1.85x | $-17.92 Million |
| 2024 | -67.50% | -780.21% | 0.04x | 1.97x | $-37.12 Million |
Industry Comparison
This section compares ASP Isotopes Inc. Common Stock's net assets metrics with peer companies in the Chemicals industry.
Industry Context
- Industry: Chemicals
- Average net assets among peers: $5,056,775,431
- Average return on equity (ROE) among peers: 5.91%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ASP Isotopes Inc. Common Stock (ASPI) | $96.60 Million | -43.48% | 1.34x | $437.78 Million |
| Synalloy Corporation (ACNT) | $26.00 Million | 24.62% | 0.65x | $96.97 Million |
| Advance ZincTek Limited (ADVNF) | $34.99 Million | 6.26% | 0.09x | $5.02 Million |
| AdvanSix Inc (ASIX) | $215.36 Million | 15.86% | 3.20x | $435.20 Million |
| Braskem SA Class A (BAK) | $5.89 Billion | 14.66% | 7.38x | $970.61 Million |
| Bachem Holding AG (BCHMF) | $389.21 Million | 11.99% | 0.14x | $1.98 Billion |
| BASF SE NA O.N. (BFFAF) | $36.11 Billion | 13.04% | 1.40x | $47.09 Billion |
| BioLargo Inc (BLGO) | $-770.20K | 0.00% | 0.00x | $51.87 Million |
| Black Swan Graphene Inc. (BSWGF) | $13.83 Million | -43.99% | 0.01x | $10.07 Million |
| Celanese Corporation (CE) | $2.83 Billion | 10.75% | 2.03x | $6.44 Billion |